Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

OpGen (OPGN)

Latest price

USD0.23

▾ −0.01 (−4.17)

As at 22/09/2023

Market capitalisation: USD2m

Equities

Equities by Sector

Sectors

Investment Strategy

Latest

Equity strategy and market outlook – August 2023

Equity strategy and market outlook – July 2023

Equity strategy and market outlook – June 2023

Thematics

Latest

The long and winding road

MediaWatch – July 2023

ConsumerWatch – July 2023

About Edison

About Edison

Careers

Healthcare Equities

OpGen (OPGN)

USD0.23

OpGen — Unyvero UTI panel approaching final readouts

OpGen — $3.38m raised through private placement

OpGen — Unyvero A30 RQ collaboration with FIND

See morecontent on

Oryzon Genomics (ORY)

EUR2.12

Oryzon Genomics — Encouraging safety data in PORTICO

Oryzon Genomics — Preclinical collaboration in orphan disease

Oryzon Genomics — Costs up but company remains well funded

See morecontent on

OSE Immunotherapeutics (OSE)

EUR4.15

OSE Immunotherapeutics — Tedopi remains focus in FY22

OSE Immunotherapeutics — Tedopi clinical data in NSCLC and PDAC

OSE Immunotherapeutics — First patient dosed with FR104/VEL-101

See morecontent on

Oxford Cannabinoid Technologies (OCTP)

GBP0.01

Paradigm Biopharma (PAR)

AUD0.62

Pharnext (ALPHA)

EUR0.10

Pharnext — Revised legal structure to offer operational stability

Pharnext — Funding headroom to support PXT3003 progress

Pharnext — €20.7m funding agreement with Neovacs inked

See morecontent on

Pixium Vision (PIX)

EUR0.04

Pixium Vision — PRIMAvera reaches full enrolment

Pixium Vision — First Prima implantation in Italy

Pixium Vision — Remote rehabilitation system approved

See morecontent on

Recce Pharmaceuticals (RCE)

AUD0.47

Renaissance BioScience (RENABIOTICKER)

—

Renaissance BioScience: Edison Open House Healthcare 2022

Renaissance BioScience — RNAi technology from bioengineered yeast

See morecontent on

ReNeuron Group (RENE)

GBP0.07

ReNeuron Group — Encouraging data for iPSCs opens potential

ReNeuron Group — Differentiating in exosome drug delivery

ReNeuron Group — Extension trial to produce data in Q122

See morecontent on

Respiri (RSH)

AUD0.03

Respiri — Objective measures for better outcomes

Respiri — Wheezo to begin patient use in the US

Respiri — NIHR funding to seek better outcomes

See morecontent on

Sareum Holdings (SAR)

GBP0.80

Sareum Holdings: Edison Open House Healthcare 2022

See morecontent on

Sequana Medical (SEQUA)

EUR3.20

Sequana Medical — POSEIDON pivotal study meets primary endpoint

Sequana Medical — Approaching key inflection points

Sequana Medical — DSR 2.0 moving forward

See morecontent on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on

See more
content on